TLSI logo

TLSI TriSalus Life Sciences, Inc.

NASDAQ Global Market · Medical - Devices · Healthcare

$5.27
+0.00 (+0.00%)

TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver and pancreatic cancers. The company's product portfolio includes the TriNav Infusion System, designed for hepatic arterial infusion to treat liver tumors, and the Pancreatic Retrograde Venous Infusion S…

Market Cap: $324.50Mtrisaluslifesci.com

Price

No data yet.

Social Signal Score

50
5d
51
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Revenue

$11.41M
$0.00$4.40M$8.80M$13.21M
Sep 2021Jun 2026